These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7382694)

  • 21. [Nitrosourea-induced lung diseases].
    Massin F; Coudert B; Foucher P; Lombard JN; Reybet-Degat O; Jeannin L; Camus P
    Rev Mal Respir; 1992; 9(6):575-82. PubMed ID: 1470749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatic damage during treatment with C.C.N.U].
    de Labarthe B; Chahinian P; Gosselin M; Goasguen J; Ferrand B; Danrigal A; Israel L
    Sem Hop Ther; 1975; 51(5-6):309-14. PubMed ID: 1224203
    [No Abstract]   [Full Text] [Related]  

  • 23. Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia.
    Cordonnier C; Vernant JP; Mital P; Lange F; Bernaudin JF; Rochant H
    Cancer; 1983 May; 51(10):1814-8. PubMed ID: 6572542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL
    Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
    [No Abstract]   [Full Text] [Related]  

  • 25. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
    Zeller WJ; Berger M
    Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCNU chemotherapy in adult patients with tumors of the basal ganglia and brain stem.
    Pompili A; Riccio A; Jandolo B; Fontana M
    J Neurosurg; 1980 Sep; 53(3):361-3. PubMed ID: 7420151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemia after therapy with methyl CCNU.
    Cohen RJ
    N Engl J Med; 1980 Jan; 302(2):120. PubMed ID: 6927914
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination chemotherapy for advanced solid tumors with methyl-ccnu and beta-2'-deoxythioguanosine.
    Brooks JC; Kaufman J; Douglass HO
    Cancer Treat Rep; 1976 Jul; 60(7):965-6. PubMed ID: 1009533
    [No Abstract]   [Full Text] [Related]  

  • 29. Nephrotoxicity of nitrosoureas.
    Schacht RG; Feiner HD; Gallo GR; Lieberman A; Baldwin DS
    Cancer; 1981 Sep; 48(6):1328-34. PubMed ID: 7272960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelofibrosis following treatment with a nitrosourea for malignant glioma.
    McKenney SA; Fehir KM
    Cancer; 1986 Oct; 58(7):1426-7. PubMed ID: 3742462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theophylline-induced lomustine toxicity.
    Zeltzer PM; Feig SA
    Lancet; 1979 Nov; 2(8149):960-1. PubMed ID: 91053
    [No Abstract]   [Full Text] [Related]  

  • 32. Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
    Zander T; Nettekoven W; Kraus JA; Pels H; Ko YD; Vetter H; Klockgether T; Schlegel U
    J Neurol; 2002 Aug; 249(8):1055-7. PubMed ID: 12195453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nephrotoxicity of lomustine. A case report and literature review.
    Ellis ME; Weiss RB; Kuperminc M
    Cancer Chemother Pharmacol; 1985; 15(2):174-5. PubMed ID: 4017166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat.
    Skorupski KA; Durham AC; Duda L; Sørenmo KU
    Vet Comp Oncol; 2008 Jun; 6(2):120-5. PubMed ID: 19178671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual abnormalities following nitrosourea treatment.
    Louie AC; Turrisi AT; Muggia FM; Bono VH
    Med Pediatr Oncol; 1978; 5(1):245-7. PubMed ID: 745590
    [No Abstract]   [Full Text] [Related]  

  • 36. Cause of variability in activity of samples of CCNU against P388 leukemia in vivo.
    Montgomery JA
    Cancer Treat Rep; 1980; 64(8-9):987-91. PubMed ID: 7448833
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of lipid association on lomustine (CCNU) administered intracerebrally to syngeneic 36B-10 rat brain tumors.
    Yimam MA; Bui T; Ho RJ
    Cancer Lett; 2006 Dec; 244(2):211-9. PubMed ID: 16455196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effect of combined hyperthermia and a nitrosourea in treatment of a murine ependymoblastoma.
    Thuning CA; Bakir NA; Warren J
    Cancer Res; 1980 Aug; 40(8 Pt 1):2726-9. PubMed ID: 7388821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inadvertent overdose with lomustine (CCNU) followed by hematologic recovery.
    Foon KA; Haskell CM
    Cancer Treat Rep; 1982 May; 66(5):1241-2. PubMed ID: 7083228
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats.
    Bethune CR; Geyer RJ; Spence AM; Ho RJ
    Cancer Res; 2001 May; 61(9):3669-74. PubMed ID: 11325837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.